Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Depo-Medrone 40mg/1ml suspension for injection vials (Pfizer Ltd) |
| BNF code | 1001022K0BBAAAA |
| Virtual Medicinal Product | Methylprednisolone acetate 40mg/1ml suspension for injection vials |
| Name | Depo-Medrone 40mg/1ml suspension for injection vials |
| Date of name applicability | 7 Jun 2004 |
| Previous name | Depo-Medrone 40mg/ml injection 1ml vials |
| Supplier | Pfizer Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intrabursal |
| Licensed Route | |
| Licenced route | Intraarticular |
| Licensed Route | |
| Licenced route | Periarticular |
| Licensed Route | |
| Licenced route | Intralesional |
| Licensed Route | |
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Depo-Medrone 40mg/1ml suspension for injection vials (Pfizer Ltd) 10 vial | |
| Depo-Medrone 40mg/1ml suspension for injection vials (Pfizer Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.